and other data for a number of reasons, such as keeping FT Sites reliable and secure,
personalising content and ads, providing social media features and to
analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Deals have been capped by growth of low-value streaming and soaring interest rates
Plus, the ‘THG loan’ that had more to it than met the eye and inside Italy’s race to sell Monte dei Paschi
London-listed music group seeks to revive stock after run of deals end
Acquirer of song catalogues from Blondie to Neil Young says market value has fallen to half the value of its catalogues
Low interest rates made investing in song catalogues a hot trend on Wall Street. As interest rates rise, what happens now?
Investors poured billions into buying rights, turning pop songs into a new asset class — but then the economy stalled
Rapid expansion of Hipgnosis Songs Fund stalls as higher interest rates start to bite
Songs fund’s yawning discount suggests scepticism about its net asset value
Deal through Hipgnosis fund could value songs at as much as $500mn
Private equity group also buys stake in Merck Mercuriadis’s company as valuations boom
Private funds gain superior visibility into business prospects
Building materials are safe as houses but only at a price; Hipgnosis’ sketchy disclosure hits all the wrong notes
The acquisitive song royalty fund shows no sign of shifting tempo.
London-listed group also scoops up Metallica producer’s catalogue as frenetic pace of acquisitions continues
The sellside have heard a bum note, or four.
Merck Mercuriadis’s group continues spending spree on hit catalogues
Beats co-founder known for work with John Lennon and Bruce Springsteen is latest to cash in on music rights boom
Songwriters deprived of touring revenue are cashing in their back catalogues but will it pay off?
Merck Mercuriadis’s music publishing group seeks to sustain spending on hit catalogues
Hipgnosis eyes £1bn deal; Warner streaming shock, a defence of Philip Green
British music fund picks up 33,000 titles in biggest acquisition to date
Music publishing company follows Hipgnosis in raising equity
This is a risky binary stock, destined for spectacular hits or misses
UK company expands song rights catalogue and adds publishing to its portfolio
Merck Mercuriadis adds to portfolio with hits including ‘Heart of Glass’ and ‘Call Me’